314 related articles for article (PubMed ID: 20216421)
21. Prospects for new tuberculosis treatment in Africa.
Mwinga A; Bernard Fourie P
Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494
[TBL] [Abstract][Full Text] [Related]
22. Management of multidrug-resistant tuberculosis: Update 2007.
Yew WW; Leung CC
Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
[TBL] [Abstract][Full Text] [Related]
23. [Tuberculosis and its control--lessons from the past and future prospect].
Shimao T
Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
[TBL] [Abstract][Full Text] [Related]
24. Clinical research in the treatment of tuberculosis: current status and future prospects.
Chang KC; Yew WW; Sotgiu G
Int J Tuberc Lung Dis; 2015 Dec; 19(12):1417-27. PubMed ID: 26614181
[TBL] [Abstract][Full Text] [Related]
25. New tuberculosis drugs on the horizon.
Cole ST; Riccardi G
Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
[TBL] [Abstract][Full Text] [Related]
26. Preclinical testing of new drugs for tuberculosis: current challenges.
Lenaerts AJ; Degroote MA; Orme IM
Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital.
Weltman AC; Rose DN
Arch Intern Med; 1994 Oct; 154(19):2161-7. PubMed ID: 7944836
[TBL] [Abstract][Full Text] [Related]
28. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
29. Drug repositioning in the treatment of malaria and TB.
Nzila A; Ma Z; Chibale K
Future Med Chem; 2011 Sep; 3(11):1413-26. PubMed ID: 21879845
[TBL] [Abstract][Full Text] [Related]
30. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Park SK; Kim CT; Song SD
Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
[TBL] [Abstract][Full Text] [Related]
31. New drugs for tuberculosis treatment.
Sánchez F; López Colomés JL; Villarino E; Grosset J
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():47-56. PubMed ID: 21420567
[TBL] [Abstract][Full Text] [Related]
32. New tuberculosis therapeutics: a growing pipeline.
Spigelman MK
J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
[TBL] [Abstract][Full Text] [Related]
33. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
34. Multidrug-resistant tuberculosis (TB) resistant to fluoroquinolones and streptomycin but susceptible to second-line injection therapy has a better prognosis than extensively drug-resistant TB.
Chan ED; Strand MJ; Iseman MD
Clin Infect Dis; 2009 Mar; 48(5):e50-2. PubMed ID: 19191632
[TBL] [Abstract][Full Text] [Related]
35. Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa.
Harries AD; Hargreaves NJ; Salaniponi FM
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1109-15. PubMed ID: 11769768
[TBL] [Abstract][Full Text] [Related]
36. Ambulatory treatment of multidrug-resistant pulmonary tuberculosis patients at a chest clinic.
Kim HJ; Hong YP; Kim SJ; Lew WJ; Lee EG
Int J Tuberc Lung Dis; 2001 Dec; 5(12):1129-36. PubMed ID: 11769771
[TBL] [Abstract][Full Text] [Related]
37. Treatment of multidrug-resistant tuberculosis: evidence and controversies.
Caminero JA; ; ;
Int J Tuberc Lung Dis; 2006 Aug; 10(8):829-37. PubMed ID: 16898365
[TBL] [Abstract][Full Text] [Related]
38. Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.
Van Deun A; Salim MA; Das AP; Bastian I; Portaels F
Int J Tuberc Lung Dis; 2004 May; 8(5):560-7. PubMed ID: 15137531
[TBL] [Abstract][Full Text] [Related]
39. New drugs for the treatment of tuberculosis: needs, challenges, promise, and prospects for the future.
Lienhardt C; Raviglione M; Spigelman M; Hafner R; Jaramillo E; Hoelscher M; Zumla A; Gheuens J
J Infect Dis; 2012 May; 205 Suppl 2():S241-9. PubMed ID: 22448022
[TBL] [Abstract][Full Text] [Related]
40. Pipeline of drugs for related diseases: tuberculosis.
Dooley KE; Nuermberger EL; Diacon AH
Curr Opin HIV AIDS; 2013 Nov; 8(6):579-85. PubMed ID: 24100880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
